These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9349473)

  • 41. In vivo immune stimulation by interferon during viral infection.
    Schellekens H; Weimar W; De Reus A; Bolhuis RL; Cantell K
    Antiviral Res; 1981 Sep; 1(3):179-83. PubMed ID: 6175277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New clues found to how some people live with HIV.
    Cohen J
    Science; 1995 Nov; 270(5238):917-8. PubMed ID: 7481790
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphocyte and macrophage responses after vaccinia virus infections.
    McLaren C; Cheng H; Spicer DL; Tompkins WA
    Infect Immun; 1976 Oct; 14(4):1014-21. PubMed ID: 992867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The negative (?) factor of HIV and SIV.
    Kirchhoff F; Hunsmann G
    Res Virol; 1992; 143(1):66-9. PubMed ID: 1565862
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.
    van der Meide PH; Harteveld N; Stebbing N; Schellekens H
    Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413
    [No Abstract]   [Full Text] [Related]  

  • 46. Supplement to the pathogenicity and immunogenicity of an attenuated vaccinia virus, strain DIs, in cynomolgus monkeys.
    Tagaya I; Amano H; Komatsu T; Uchida N; Kodama H
    Jpn J Med Sci Biol; 1974 Aug; 27(4):215-28. PubMed ID: 4547313
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.
    Okada H; Wakamiya N; Okada N; Kato S
    Cancer Immunol Immunother; 1987; 25(1):7-9. PubMed ID: 3594492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
    Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
    J Virol; 2005 Mar; 79(5):3229. PubMed ID: 15709047
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vaccinal virus, serological reactions and immunity].
    FASQUELLE R
    Bull Acad Natl Med; 1960 Jan 5-12; 144():20-2. PubMed ID: 13821670
    [No Abstract]   [Full Text] [Related]  

  • 50. Egg cultivated tumor protects embryo against vaccinia virus.
    TAYLOR A; CARMICHAEL N
    Proc Soc Exp Biol Med; 1953; 83(4):676-8. PubMed ID: 13120850
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.
    Kaulfuß M; Wensing I; Windmann S; Hrycak CP; Bayer W
    Retrovirology; 2017 Feb; 14(1):8. PubMed ID: 28166802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma.
    Stahl-Hennig C; Gundlach BR; Dittmer U; ten Haaft P; Heeney J; Zou W; Emilie D; Sopper S; Uberla K
    Virology; 2003 Jan; 305(2):473-85. PubMed ID: 12573592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Attenuated" simian immunodeficiency virus in macaque neonates.
    Ruprecht RM; Baba TW; Liska V; Bronson R; Penninck D; Greene MF
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):459-60. PubMed ID: 8882333
    [No Abstract]   [Full Text] [Related]  

  • 55. No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation.
    Dittmer U; Nisslein T; Meyerhans A; Hunsmann G; Stahl-Hennig C
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2523-8. PubMed ID: 9349473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.